Daxor Management

Management criteria checks 4/4

Daxor's CEO is Michael Feldschuh, appointed in Sep 2016, has a tenure of 7.58 years. total yearly compensation is $100.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 3.38% of the company’s shares, worth $1.55M. The average tenure of the management team and the board of directors is 5.6 years and 5.5 years respectively.

Key information

Michael Feldschuh

Chief executive officer

US$100.0k

Total compensation

CEO salary percentage100.0%
CEO tenure7.6yrs
CEO ownership3.4%
Management average tenure5.6yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Daxor reports Q2 results

Aug 25

Daxor partners with Medaxiom to advance awareness of blood volume diagnostic

Jul 21

Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

Mar 08
Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Feb 27
A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

CEO Compensation Analysis

How has Michael Feldschuh's remuneration changed compared to Daxor's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

US$281k

Sep 30 2023n/an/a

US$2m

Jun 30 2023n/an/a

US$4m

Mar 31 2023n/an/a

US$5m

Dec 31 2022US$100kUS$100k

US$5m

Sep 30 2022n/an/a

US$5m

Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

US$5m

Dec 31 2021US$100kUS$100k

US$5m

Sep 30 2021n/an/a

US$3m

Jun 30 2021n/an/a

US$294k

Mar 31 2021n/an/a

-US$706k

Dec 31 2020US$100kUS$100k

-US$2m

Sep 30 2020n/an/a

-US$3m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$2m

Dec 31 2019US$100kUS$100k

-US$496k

Sep 30 2019n/an/a

-US$149k

Jun 30 2019n/an/a

US$197k

Mar 31 2019n/an/a

-US$344k

Dec 31 2018US$100kUS$100k

-US$886k

Sep 30 2018n/an/a

-US$1m

Jun 30 2018n/an/a

-US$1m

Mar 31 2018n/an/a

-US$1m

Dec 31 2017US$100kUS$100k

-US$1m

Compensation vs Market: Michael's total compensation ($USD100.00K) is below average for companies of similar size in the US market ($USD674.64K).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.


CEO

Michael Feldschuh (54 yo)

7.6yrs

Tenure

US$100,000

Compensation

Mr. Michael Richard Feldschuh has been the Chief Executive Officer and President of Daxor Corp. since September 21, 2016. Mr. Feldschuh served as Acting Chief Executive Officer and President of Daxor Corp....


Leadership Team

NamePositionTenureCompensationOwnership
Michael Feldschuh
Chairman7.6yrsUS$100.00k3.38%
$ 1.6m
Jonathan Feldschuh
Chief Scientific Officer & Directorno dataUS$127.92k0.081%
$ 37.6k
Robert Michel
CFO, Chief Compliance Officer & Corporate Secretary5.6yrsno data0.24%
$ 108.6k
Linda Cooper
Vice President of Development & Operations1.3yrsno datano data
Kathryn Kornafel
Senior VP of Marketing & Commercial Development5.8yrsno datano data
Guido Manzo
Vice President of Sales5.3yrsno datano data
Jean Oertel
Senior Vice President Commercialization & Customer Experienceno datano datano data

5.6yrs

Average Tenure

58yo

Average Age

Experienced Management: DXR's management team is seasoned and experienced (5.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michael Feldschuh
Chairman11.3yrsUS$100.00k3.38%
$ 1.6m
Jonathan Feldschuh
Chief Scientific Officer & Director7.2yrsUS$127.92k0.081%
$ 37.6k
Phillip Frost
Chairman of Medical Advisory Boardno datano datano data
Caleb DesRosiers
Independent Director2.3yrsUS$1.75k0.066%
$ 30.3k
Fred Gilbert
Member of Medical Advisory Boardno datano datano data
James Brassel
Member of Medical Advisory Boardno datano datano data
Edward Feuer
Independent Director8.3yrsUS$2.13k0.021%
$ 9.6k
Henry Cremisi
Independent Director3.8yrsUS$750.000%
$ 0
Joy Goudie
Independent Director3.8yrsUS$2.13k0.0062%
$ 2.9k

5.5yrs

Average Tenure

65yo

Average Age

Experienced Board: DXR's board of directors are considered experienced (5.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.